Intraocular Optic Capture Device (IOCD)

Competitive Advantages

  • Made of FDA approved material
  • Minimal incision required
  • Compatible with single-piece IOL’s including premium lenses
  • Allows re-fixation of dislocated toric IOL’s

Summary

A device called Intraocular Optic Capture Device (IOCD) was developed by USF researchers for IOL re-fixation. The first of its kind, this invention is designed to restore the function of a lens capsule, a support structure which is lost in patients with dislocated IOL’s. The IOCD uses a technique called optic capture to safely position the IOL inside the eye. By simulating the function of a lens capsule, the device allows positioning of even single-piece IOL’s without the need to introduce a new IOL. The device also can be used for repositioning of toric IOL’s in their correct alignment. The IOCD is made of an FDA approved acrylic material which is proven safe for use inside the body. This material is thin and flexible and can be inserted into the eye through small corneal incisions. The Intraocular Optic Capture Device provides a new surgical paradigm to surgeons and offers patients a second chance to regain their vision.

Schematic of Eye with IOL Lens 

Desired Partnerships

  • License
  • Sponsored Research
  • Co-Development
Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date
Intraocular Lens Repositioning Device Provisional United States 62/994,450   3/25/2020   3/25/2021